Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma
Published in Neuro-Oncology Advances, 2023
This paper develops MRI-based radiomic models to distinguish pseudoprogression from true tumor progression in glioblastoma.
Citation: Leone R. et al. (2023). ‘Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma.’ Neuro-Oncology Advances. 5(1):vdad016.
Recommended citation: Leone R. et al. (2023). 'Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma.' Neuro-Oncology Advances. 5(1):vdad016.
Download Paper
